- Price is above Fair Value, showing premium demand versus the model.
VBK
GER
Week ended 07 Aug 2026
Weekly Investor Report
Verbio SE · Basic Materials · Specialty Chemicals
Latest close
29.68 EUR
3.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -8.7% below the Trend Line and sits at 53.1% of its 52-week range. The latest completed week returned 3.5%, after a -2.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100.
Setup score
41
out of 100
Latest Close
29.68 EUR
7 Aug 2026
1W Return
3.5%
latest completed week
4W Return
-2.3%
short-term follow-through
12W Return
-25.4%
quarterly tape
Trend Breadth
88.5%
46 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.5%
Latest completed week; four-week move -2.3%.
Indicator stack
49/35
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
54/100
8 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -8.7% below the Trend Line and sits at 53.1% of its 52-week range. The latest completed week returned 3.5%, after a -2.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4012-week average 0.68
12-week confirmation
Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.40Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.3% over four weeks, -25.4% over 12 weeks, and 181.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year46
Trend breadth88.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.97Latest activity-pressure read.
Pressure change25.4%Four-week change in activity pressure.
Leadership9.42Latest relative-leadership reading.
RS change-61.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength26/100Blend of value, momentum, and quality. Underlying universe rank 75; rank 1 is best.
Value29/100Relative valuation strength. Underlying universe rank 72; rank 1 is best.
Quality5/100Profitability and accounting quality. Underlying universe rank 96; rank 1 is best.
Momentum98/100Medium-term price momentum. Underlying universe rank 3; rank 1 is best.
Growth24/100Revenue and earnings growth. Underlying universe rank 77; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 1.1x Market value relative to trailing revenue.
- EV / EBITDA
- 20.6x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 1.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 15.8% Gross profit retained from each unit of revenue.
- Operating margin
- -3.4% Operating profit retained from revenue.
- Free-cash-flow margin
- 1.2% Free cash flow generated from revenue.
- Return on invested capital
- -4.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -4.7% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.7% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.7% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 8 relevant articles.
2 positive · 6 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-37.2%Distance below the 52-week high.
13-week volatility8.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+20.0%Week of 13 Mar.
Worst week-15.7%Week of 12 Jun.
Latest week+3.5%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains3
Flat weeks0
Modest losses7
Sharp losses7
Recent vol8.0%13-week weekly-return volatility.
Base vol8.2%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew8.9% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Basic Materials
4-week rank33 / 44
Group average3.5%
Trend breadth47.7%
Trend47.7%active weekly trend signals
MD20.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryDE Specialty Chemicals
4-week rank13 / 18
Group average1.0%
Trend breadth61.1%
Trend61.1%active weekly trend signals
MD44.4%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape45/100
Trend, activity pressure, participation, and risk combine to a 45/100 tape read.
Indicator analysis45/100Latest 12-week confirmation: trend 6/12, activity pressure 0/12, relative leadership 12/12.
Activity pressure 0.40; 1 reversal markers Factors36/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 83; Small Cap Core rank 76 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 8 relevant articles.
Verbio SE Revenue Breakdown – SWB:VBK Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 29.68 EUR | 3.5% | 32.50 EUR | 20.65 EUR | -0.97 | 9.42 | 461.1K | Off |
| 31 Jul 2026 | 28.68 EUR | -11.2% | 32.24 EUR | 20.73 EUR | -1.00 | 10.00 | 418.7K | Off |
| 24 Jul 2026 | 32.30 EUR | 0.7% | 32.03 EUR | 20.83 EUR | -1.03 | 28.05 | 562.3K | Off |
| 17 Jul 2026 | 32.08 EUR | 5.6% | 31.60 EUR | 20.89 EUR | -1.18 | 30.49 | 814.2K | Off |
| 10 Jul 2026 | 30.38 EUR | -1.3% | 31.19 EUR | 20.94 EUR | -1.30 | 24.31 | 464.9K | Off |
| 3 Jul 2026 | 30.78 EUR | 9.9% | 30.77 EUR | 20.98 EUR | -1.32 | 24.20 | 50.1K | Off |
| 26 Jun 2026 | 28.00 EUR | -11.1% | 30.36 EUR | 21.02 EUR | -1.19 | 19.62 | 240.9K | On |
| 19 Jun 2026 | 31.50 EUR | -0.8% | 30.02 EUR | 21.07 EUR | -0.95 | 34.58 | 245.5K | On |
| 12 Jun 2026 | 31.76 EUR | -15.7% | 29.51 EUR | 21.11 EUR | -0.73 | 39.84 | 163.9K | On |
| 5 Jun 2026 | 37.68 EUR | -0.6% | 29.02 EUR | 21.17 EUR | -0.35 | 67.98 | 45.5K | On |
| 29 May 2026 | 37.90 EUR | -0.3% | 28.31 EUR | 21.17 EUR | -0.20 | 70.70 | 764.4K | On |
| 22 May 2026 | 38.00 EUR | -4.4% | 27.56 EUR | 21.15 EUR | -0.01 | 76.95 | 662.2K | On |
| 15 May 2026 | 39.76 EUR | 13.5% | 26.81 EUR | 21.12 EUR | 0.25 | 97.39 | 1.1M | On |
| 8 May 2026 | 35.02 EUR | -7.2% | 25.93 EUR | 21.07 EUR | 0.39 | 76.19 | 877.2K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.